What is the fetal vessel that connects the pulmonary artery to the descending thoracic aorta?

The ductus arteriosus is a vital fetal blood vessel connecting the pulmonary artery to the descending thoracic aorta. It allows the majority of right ventricular output to bypass the non-functioning fetal lungs and enter the systemic circulation directly.

Structure & Function

• Anatomy: Short, muscular artery (1–2 cm) arising from the pulmonary trunk/left pulmonary artery, inserting into the aortic arch distal to the left subclavian artery.
• Flow Direction: Right ventricle → pulmonary artery → ductus arteriosus → descending aorta → placenta (via umbilical arteries) for oxygenation.
• Oxygen Saturation: Mixed blood in descending aorta ~60–65% saturated (vs. 95% postnatal).

Physiological Regulation

• Patency Maintained By: Low PO₂, high prostaglandins (PGE₂, PGI₂) from placenta and ductal tissue.
• Functional Closure (Hours–Days Postpartum): ↑ PO₂ (lung inflation) + ↓ prostaglandins → smooth muscle contraction → functional closure.
• Anatomic Closure (Weeks–Months): Intimal thickening, fibrosis → ligamentum arteriosum (fibrous remnant).

Clinical Significance

• Patent Ductus Arteriosus (PDA): Failure to close → left-to-right shunt → pulmonary overcirculation, heart failure. Common in preemies. Treated with indomethacin/ibuprofen (prostaglandin inhibitors) or surgical/device closure.
• Ductal-Dependent Lesions: Certain congenital heart defects (e.g., pulmonary atresia, critical coarctation, HLHS) require PDA patency for survival → maintained with PGE₁ infusion until surgery.
• Prostaglandin Inhibition (NSAIDs) in Late Pregnancy: Risk of premature closure → fetal pulmonary hypertension, right heart failure.

The ductus arteriosus is a marvel of fetal circulatory engineering—essential in utero, programmed to close at birth, and a critical therapeutic target in congenital heart disease.